WAYCROSS PARTNERS, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1844873 LOUISVILLE, KY

Position in GILD

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$724,180

-$74,688 QoQ

Shares Held

5,732

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,217

of 2,266 holders

Holding Since

Mar 2021

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

WAYCROSS PARTNERS, LLC holds $44,812,679 across 6 Drug Manufacturers - General names. GILD ranks #3 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	167,931	$42,258,156
2	AMGN	Amgen Inc	2,250	$814,770
3	GILD	Gilead Sciences, Inc. This page	5,732	$724,180
4	JNJ	Johnson & Johnson	1,700	$431,749
5	MRK	Merck & Co., Inc.	2,500	$321,250
6	BMY	Bristol Myers Squibb Co	4,557	$262,574

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$724,180	5,732	0.0%	Shares	Sole	2026-08-11
2026-03-31	$798,868	5,732	0.0%	Shares	Sole	2026-05-07
2025-12-31	$703,545	5,732	0.0%	Shares	Sole	2026-01-14
2025-09-30	$636,252	5,732	0.0%	Shares	Sole	2025-11-07
2025-06-30	$635,506	5,732	-59.1%	Shares	Sole	2025-07-15
2021-09-30	$977,900	14,000	0.0%	Shares	Sole	2021-11-10
2021-06-30	$964,040	14,000	0.0%	Shares	Sole	2021-08-17
2021-03-31	$904,820	14,000	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.